- Sort by:
- Browse by:
- Permission not
granted for presentation
Computationally assessing the origins of tumor aggressivity
Paul C Boutros
UCLA, Los Angeles, CA, United States
- Free
- slides video
- audio + slides
- All slides included
DNA damage responses: Canonical to noncanonical
Michael B Kastan
Duke Cancer Institute, Durham, NC, United States
- Free
- audio + slides
- Some slides withheld
High-dimensional single-cell mass cytometry in translational cancer research
Kara L. Davis
Stanford Univ., Stanford, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Where things stand today: A realistic appraisal of boron neutron capture therapy as a cancer treatment modality
Rolf F Barth
Ohio State Univ., Columbus, OH, United States
- Free
- slides video
- audio + slides
- All slides included
BNCT Physics
Hanna Koivunoro
Neutron Therapeutics and University of Helsinki, Helsinki, Finland
- Free
- Coming soon
- Some slides withheld
BNCT in treatment of head and neck cancer
Leena Kankaanranta
Helsinki Univ. Central Hospital, Helsinki, Finland
- Free
- audio + slides
- Some slides withheld
Experience of BNCT for glioblastoma and current status of accelerator based BNCT
Akira Matsumura
University of Tsukuba, Tsukuba, Japan
- Free
- slides video
- audio + slides
- All slides included
Targeting master transcription factor dependency in pediatric cancer
Charles Lin
Baylor College of Medicine, Houston, TX, United States
- Free
- slides video
- audio + slides
- All slides included
Neuroblastoma: A developmental twist
Rogier Versteeg
dept. of Oncogenomics, Amsterdam UMC - Univ. of Amsterdam, Amsterdam, Netherlands
- Permission not
granted for presentation
Core regulatory circuitries and dependencies in pediatric cancer
Kimberly Stegmaier
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Integrating genomics into precision cancer medicine
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
- Free
- slides video
- audio + slides
- All slides included
Targeting ALK in neuroblastoma: From discovery to phase 3 and back to the lab
Yael P Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Chairperson
Sharon Y R Dent
UT MD Anderson Cancer Ctr., Smithville, TX, United States
- Permission not
granted for presentation
SAGA functions in development and disease
Sharon Y R Dent
UT MD Anderson Cancer Ctr., Smithville, TX, United States
- Free
- audio only
- Audio only
Aberrant polycomb repression in midline and hindbrain tumors
Peter W Lewis
University of Wisconsin-Madison, Madison, WI, United States
- Permission not
granted for presentation
Principles of epigenetics and chromatin in development and human disease
Ali Shilatifard
Northwestern Univ. Feinberg School of Medicine, Chicago, IL, United States
- Permission not
granted for presentation
Chemical biology-based approach to understanding and overcoming resistance of cancers to therapies
Stuart L Schreiber
Harvard University and Broad Institute, Cambridge, MA, United States
- Free
- Coming soon
- Some slides withheld
Inactivating STK11/LKB1 genomic alterations are a major driver of primary resistance to PD-1 axis blockade in non-squamous non-small cell lung cancer
Ferdinandos Skoulidis
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Permission not
granted for presentation
Strategies to overcome resistance to targeted therapy of lymphoma based on functional genomic and chemical screens
Louis M Staudt
National Cancer Institute, Bethesda, MD, United States
- Free
- audio + slides
- Some slides withheld
Systematic interrogation of cancer dependencies and synthetic lethal interactions
William C Hahn
Dana-Farber Cancer Inst., Boston, MA, United States
- Permission not
granted for presentation
A chromatin trans-regulatory pathway implicated in cancer and developmental overgrowth
Chao Lu
Columbia University, New York, NY, United States
- Permission not
granted for presentation
Fusion oncogenes co-opt developmental programs for rhabdomyosarcoma tumorigenesis
Genevieve C. Kendall
UT Southwestern Medical Ctr., Dallas, TX, United States
- Free
- slides video
- audio + slides
- All slides included
Implications of T cell variance in pediatric immunotherapy
David M Barrett
Children's Hospital of Philadelphia, Philadelphia, PA, United States
- Free
- audio only
- Audio only
Initiation of FN-RMS from endothelial progenitors
Catherine J Drummond
University of Otego, Dunedin, New Zealand
- Free
- audio + slides
- Some slides withheld
Discovery and development of GPC2 as an immunotherapeutic target in neuroblastoma and other cancers
Kristopher R Bosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States